Evommune (EVMN) Change in Acquisitions & Divestments (2024 - 2026)

Evommune (EVMN) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $23.5 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 74.07% year-over-year to $23.5 million in Q1 2026; TTM through Mar 2026 was $86.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $84.1 million, down 2.61% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $23.5 million, down from $37.6 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for EVMN reached as high as $37.6 million in Q4 2025 and fell as low as $11.5 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $21.5 million across 3 years, with a median of $18.5 million in 2025.
• Across the five-year window, Change in Acquisitions & Divestments surged 226.96% in 2025 and soared 74.07% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $11.5 million in 2024, then jumped by 226.96% to $37.6 million in 2025, then plunged by 37.5% to $23.5 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $23.5 million in Q1 2026, $37.6 million in Q4 2025, and $13.5 million in Q1 2025.